Addressing heterogenous outcomes in uterine fibroid research: a call to action

Marsh, 2018, Burden, prevalence, and treatment of uterine fibroids: a survey of U.S. women, J Womens Health, 27, 1359, 10.1089/jwh.2018.7076 Drayer, 2015, Prevalence, morbidity, and current medical management of uterine leiomyomas, Int J Gynecol Obstet, 131, 117, 10.1016/j.ijgo.2015.04.051 Yao, 2017, Medical therapies for heavy menstrual bleeding in women with uterine fibroids: a retrospective analysis of a large commercially insured population in the USA, BJOG, 124, 322, 10.1111/1471-0528.14383 Day Baird, 2003, High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence, Am J Obstet Gynecol, 188, 100, 10.1067/mob.2003.99 Stewart, 2017, Epidemiology of uterine fibroids: a systematic review, BJOG, 124, 1501, 10.1111/1471-0528.14640 Pavone, 2018, Epidemiology and risk factors of uterine fibroids, Best Pract Res Clin Obstet Gynaecol, 46, 3, 10.1016/j.bpobgyn.2017.09.004 Donnez, 2016, Uterine fibroid management: from the present to the future, Hum Reprod Update, 22, 665, 10.1093/humupd/dmw023 Laughlin-Tommaso, 2018, Moving toward individualized medicine for uterine leiomyomas, Obstet Gynecol, 132, 961, 10.1097/AOG.0000000000002785 Stewart, 2015, Uterine fibroids, N Engl J Med, 372, 1646, 10.1056/NEJMcp1411029 Farris, 2019, Uterine fibroids: an update on current and emerging medical treatment options, Ther Clin Risk Manag, 15, 157, 10.2147/TCRM.S147318 2001, ACOG Practice Bulletin: surgical alternatives to hysterectomy in the management of leiomyomas, Int J Gynecol Obstet, 73, 285, 10.1016/S0020-7292(01)00414-3 Stewart, 2018, The comparing options for management: PAtient-centered REsults for Uterine Fibroids (COMPARE-UF) registry: rationale and design, Am J Obstet Gynecol, 219, 95.e1, 10.1016/j.ajog.2018.05.004 Hartmann, 2017, Management of uterine fibroids: comparative effectiveness review no. 195, Rockville, MD: AHRQ; Chittawar, 2014, Minimally invasive surgical techniques versus open myomectomy for uterine fibroids, Cochrane Database Syst Rev, 10 Gupta, 2014, Uterine artery embolization for symptomatic uterine fibroids, Cochrane Database Syst Rev, 12 Lethaby, 2017, Preoperative medical therapy before surgery for uterine fibroids, Cochrane Database Syst Rev, 11 Moroni, 2015, Add-back therapy with GnRH analogues for uterine fibroids, Cochrane Database Syst Rev, 3 Murji, 2017, Selective progesterone receptor modulators (SPRMs) for uterine fibroids, Cochrane Database Syst Rev, 4 Bofill Rodriguez, 2019, Endometrial resection and ablation techniques for heavy menstrual bleeding, Cochrane Database Syst Rev, 1 Kirkham, 2013, Can a core outcome set improve the quality of systematic reviews? A survey of the Co-ordinating Editors of Cochrane review groups, Trials, 14, 21, 10.1186/1745-6215-14-21 Williamson, 2012, Developing core outcome sets for clinical trials: issues to consider, Trials, 13, 132, 10.1186/1745-6215-13-132 Khan, 2014, The CROWN Initiative: journal editors invite researchers to develop core outcomes in women’s health, BJOG, 121, 1181, 10.1111/1471-0528.12929 Duffy, 2017, Core outcome sets in women’s and newborn health: a systematic review, BJOG, 124, 1481, 10.1111/1471-0528.14694 Iorio, 2018, Core outcome set for gene therapy in haemophilia: results of the coreHEM multistakeholder project, Haemophilia, 24, e167, 10.1111/hae.13504 Herman, 2016, Choice of primary outcomes evaluating treatment for heavy menstrual bleeding, BJOG, 123, 1593, 10.1111/1471-0528.14054 Duffy, 2019, Tackling poorly selected, collected, and reported outcomes in obstetrics and gynecology research, Am J Obstet Gynecol, 220, 71.e1, 10.1016/j.ajog.2018.09.023 Magnay, 2018, A systematic review of methods to measure menstrual blood loss, BMC Womens Health, 18, 142, 10.1186/s12905-018-0627-8 Sherman, 2016, Real-world evidence: what is it and what can it tell us?, N Engl J Med, 375, 2293, 10.1056/NEJMsb1609216